| Application no. and date | 11829686.2 (espacenet) (Federated) (European Patent Register), 20110929 | | Patent/reg. no. and date | DK/EP 2621496, 20151216 | | Publication date | 20130807 | | Priority no. and date | US 388501 P, 20100930 | | EP pub. no. and date |
EP 2621496 20130807 | | Effective date | | | Applicant/owner | Grünenthal GmbH, Zieglerstrasse 6
D-52078 Aachen, DE,
Nektar Therapeutics, 455 Mission Bay Boulevard South, Suite 100
San Francisco, CA 94185, US | | Applicant ref. no. | AstraZeneca 104068-EP-EPT | | Inventor | LECHUGA-BALLESTEROS, David, 1879 Blossom Hill Road
San Jose
California 95124, US,
AURELL, Carl-Johan, AstraZeneca R&D Södertälje
SE-151 85 Södertälje, SE,
BOHLIN, Martin Hans, AstraZeneca R&D Södertälje
SE-151 85 Södertälje, SE,
SEBHATU, Tesfai, AstraZeneca R&D Södertälje
SE-151 85 Södertälje, SE,
YMÉN, Bo Ingvar, AstraZeneca R&D Södertälje
SE-151 85 Södertälje, SE,
HEALY, Eric Thomas, Nektar Therapeutics
455 Mission Bay Boulevard South, Suite 100
San Francisco, California 94158, US,
JENSEN, David Richard, Nektar Therapeutics
455 Mission Bay Boulevard South, Suite 100
San Francisco, California 94158, US,
JONAITIS, David Thomas, SSCI
A Division of APTUIT
3065 Kent Avenue
West Lafayette, Indiana 47906-1076, US,
PARENT, Stephan, SSCI
A Division of APTUIT
3065 Kent Avenue
West Lafayette, Indiana 47906-1076, US,
ASLUND, Bengt Leonard, AstraZeneca R&D Södertälje
SE-151 85 Södertälje, SE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 47/48 (2006.01) , A61P 39/00 (2006.01) , C07D 489/04 (2006.01) | | Title | KRYSTALLINSK NALOXOL-PEG-KONJUGAT | | Int. application no. | SE2011051161 | | Int. publication no. | WO2012044243 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
